¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"gradient induced phase shift effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • induced malaria
    Á¢Á¾¸»¶ó¸®¾Æ
  • induced mutation
    À¯¹ßµ¹¿¬º¯ÀÌ
  • induced ovulation
    À¯µµ¹è¶õ
  • induced psychosis
    À¯µµÁ¤½Åº´
  • induced reaction
    À¯¹ß¹ÝÀÀ
  • induced shock
    À¯µµ¼îÅ©
  • induced sleep
    À¯µµ¼ö¸é
  • induced spindle burst
    À¯¹ß¹æÃßµ¹¹ßÆÄ
  • induced symptom
    À¯¹ßÁõ»ó
  • insulin-induced hypoglycemia
    Àν¶¸°À¯µµÀúÇ÷´ç(Áõ)
  • lens-induced glaucoma
    ¼öÁ¤Ã¼³ì³»Àå
  • lens-induced uveitis
    ¼öÁ¤Ã¼Æ÷µµ¸·¿°
  • neuroleptic-induced disorder
    Ç×Á¤½Åº´¾à¹°À¯¹ßÀå¾Ö
  • noise induced hearing loss
    ¼ÒÀ½³­Ã»
  • pregnancy induced retinopathy
    ÀÓ½ÅÀ¯¹ß¸Á¸·º´(Áõ)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • drug-induced retinopathy
    ¾àÀ¯¹ß¸Á¸·º´Áõ
  • drug-induced rhinitis
    ¾à¹°À¯¹ßÄÚ¿°, ¾à¹°À¯¹ßºñ¿°
  • induced delivery
    À¯µµºÐ¸¸
  • neuroleptic-induced disorder
    ½Å°æÀÌ¿ÏÁ¦À¯¹ßÀå¾Ö
  • induced enzyme
    À¯µµÈ¿¼Ò
  • fat induced hyperlipemia
    ÁöÁúÀ¯µµ°íÁö¹æÇ÷Áõ
  • lens-induced glaucoma
    ¼öÁ¤Ã¼³ì³»Àå
  • steroid-induced glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • induced hibernation
    À¯µµµ¿¸é
  • induced hypothermia
    À¯µµÃ¼¿ÂÀúÇÏ
  • insulin-induced hypoglycemia
    Àν¶¸°À¯µµÀúÇ÷´ç(Áõ)
  • noise induced hearing loss
    ¼ÒÀ½³­Ã»
  • induced
    À¯¹ß-, À¯µµ-
  • induced insanity
    À¯¹ßÁ¤½Åº´
  • induced labor
    À¯µµºÐ¸¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • T1 induced dephasing
    T1 À¯µµ Å»À§»ó
  • abactio =induced abortion, abactus venter<³ª>
    ÀΰøÀ¯»ê(ìÑÍïêüß§).
  • antibiotic-induced colitis (AAC)
    Ç×»ýÁ¦À¯¹ß´ëÀå¿°, Ç×»ýÁ¦À¯¹ß¼³»ç
  • artificial hibernation =induced h.
    Àΰøµ¿¸é(¹ý)(¡­ÔÏØùÛö), ¾à¹°µ¿¸é(¹ý).
  • hallucinogen-induced disorder
    ȯ°¢Á¦ À¯¹ß¼ºÀå¾Ö(º´)(ü³ÊÆð¥ë¯Û¡àõî¡äô)
  • hearing loss, noise induced
    ¼ÒÀ½¼º³­Ã»
  • heat induced hemolytic anemia
    ¿­À¯¹ß¼º ¿ëÇ÷¼º ºóÇ÷
  • induced abortion =provoked a.
    À¯¹ßÀ¯»ê(ë¯Û¡êüß§), ÀΰøÀ¯»ê(ìÑÍïêüß§) .
  • induced allergy
    À¯¹ß(¼º)¾Ë·¹¸£±â.
  • induced allergy
    À¯¹ß(¼º)¾Ë·¹¸£±â
  • induced delivery
    À¯µµºÐ¸¸.
  • induced delusional disorder
    À¯¹ß¼º ¸Á»óÀå¾Ö, ~¸Á»óº´
  • induced enzyme
    À¯µµÈ¿¼Ò.
  • induced hibernation =artificial h.
    À¯µµ¼º µ¿¸é.
  • induced hypotension =controlled hibernation
    À¯µµ¼º ÀúÇ÷¾Ð(¹ý), Á¶ÀýÀúÇ÷¾Ð(¹ý)(ðàï½î¸úìäâÛö).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • temporary threshold shift
    Àϰú¼º ¿ªÄ¡º¯µ¿ (ìéΦàõæ´ö·Ü¨ÔÑ)
  • abactio =induced abortion, abactus venter<³ª>
    ÀΰøÀ¯»ê(ìÑÍïêüß§).
  • active gradient shielding
    ´Éµ¿ °æ»ç Â÷Æó
  • alcohol induced hypoglycemia
    ¾ËÄڿñâÀÎ(¼º) ÀúÇ÷´ç.
  • alveolar O2 pressure gradient
    ÆóÆ÷³» »ê¼Ò ºÐ¾ÐÂ÷.
  • alveolar arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷.
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷
  • antibiotic-induced colitis (AAC)
    Ç×»ýÁ¦À¯¹ß´ëÀå¿°, Ç×»ýÁ¦À¯¹ß¼³»ç
  • artificial hibernation =induced h.
    Àΰøµ¿¸é(¹ý)(¡­ÔÏØùÛö), ¾à¹°µ¿¸é(¹ý).
  • axial gradient
    üÃà±â¿ï±â, üÃà°æ»ç (¡­ÌËÞØ)
  • background gradient
    ¹è°æ °æ»ç
  • bipolar gradient
    ¾ç±Ø °æ»ç
  • bipolar velocity encoding gradient
    ¾ç±Ø ¼Óµµ ºÎȣȭ °æ»ç
  • complement-induced = complement-mediated
    º¸Ã¼¸Å°³¼º
  • concentration gradient
    ³óµµ°æ»ç(¡­ÌËÞØ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • gradient curve
    ±¸¹è °î¼±(ÎþÛÕÍØàÊ)
  • gradient elution
    ±¸¹è ¿ë¸®(ÎþÛÕéÁ×î)
  • gradient-flow method
    ±¸¹è(ÎþÛÕ)-È帧¹ý(Ûö)
  • gradient gel electrophoresis
    ±¸¹è(ÎþÛÕ) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • gradient layer
    ±¸¹èÃþ(ÎþÛÕöµ)
  • gradient mixer
    ±¸¹è È¥ÇÕ±â(ÎþÛÕûèùêÐï)
  • gradient plate technique
    ±¸¹è ÆÇ(ÎþÛÕ÷ù)¼ú(âú)
  • gradient sievorptive chromatography
    ±¸¹è ¿©°úÈíÂø(ÎþÛÕÕëΦýåó·) Å©·Î¸¶Åä±×·¡ÇÇ
  • isokinetic gradient
    µî¿ªÇÐ ±¸¹è(ÔõÕôùÊÎøÛÎ)
  • isopycnic gradient centrifugation
    µî¹Ðµµ±¸¹è¿ø½ÉºÐ¸®(ÔõÚËÓøÎøÛÎêÀãýÝÂ×î)
  • linear density gradient
    ¼± ¹Ðµµ(à»ÚËÓø)±â¿ï±â
  • pH gradient electrophoresis
    pH ±¸¹è Àü±â¿µµ¿(ÎþÛÕï³Ñ¨ç¶ÔÑ)
  • potential gradient
    "ÀüÀ§ ±¸¹è(ï³êÈÎþÛÕ), ÆÛÅÙ¼È ±¸¹è(ÎþÛÕ)"
  • preformed gradient isodensity centrifugation
    ±âÇü¼º ±¸¹è(Ðþû¡à÷ÎþÛÕ) ¾ÆÀ̼ҹеµ ¿ø½ÉºÐ¸®(ÚËÓøêÀãýÝÂ×î)
  • proton gradient
    ¾ç¼ºÀÚ ±â¿ï±â
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • paramagnetic susceptibility effect
    »óÀÚ¼ºÀÚ±âÈ­È¿°ú
  • partial volume effect
    ºÎºÐ¿ëÀûÈ¿°ú
  • photoelectric effect
    ±¤ÀüÈ¿°ú
  • piezoelectric effect
    ¾ÐÀüÈ¿°ú
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • radio-frequency thermal effect
    °íÁÖÆÄ¿­È¿°ú
  • reverse piezoelectric effect
    ¿ª¾ÐÀüÈ¿°ú
  • RF antennae effect
    °íÁ֯ľÈÅ׳ªÈ¿°ú
  • shielding effect
    Â÷ÆóÈ¿°ú
  • siphonage effect
    ½ÎÀÌÆùÈ¿°ú
  • spatial presaturation effect
    °ø°£ÀüÆ÷È­È¿°ú
  • T1 shortening effect
    T1´ÜÃàÈ¿°ú
  • T2 shortening effect
    T2´ÜÃàÈ¿°ú
  • volume averaging effect
    ¿ëÀûÆò±ÕÈ­È¿°ú
  • 3D phase contrast angiography
    3Â÷¿øÀ§»ó´ëÁ¶ Ç÷°üÃÔ¿µ¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
EMSA electrophoretic mobility shift assay
LSR lanthanide shift reagent; lecithin/ sphingomyelin ratio; left superior rectus [muscle]; liver/spleen...
MS Maffuci syndrome; maladjustment score; mandibular series; Marfan syndrome; Marie-Strumpell [syndrome...
NSCS night shift call system
PDS pain-dysfunction syndrome; paroxysmal depolarizing shift; patient data system; Patient-Doctor Societ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
TS threshold shift
AaDO2 Alveolar-arterial oxygen gradient
DGGE Denaturing Gradient Gel Electrophoresis
GE Gradient Echo
GRE Gradient Echo
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • drug-induced allergic hepatopathy
    ¾à¹° ¾Ë·¹¸£±â¼º °£º´Áõ, ¾à¹° À¯¹ß ¾Ë·¹¸£±â¼º °£º´Áõ
  • drug-induced autoantibody
    ¾à¹° À¯Àμº ÀÚ°¡ Ç×ü
  • drug-induced cholestais
    ¾àÁ¦¼º ´ãÁó ¿ïü
  • drug-induced enanthema
    ¾à¹° À¯µµ¼º Á¡¸·Áø
  • drug-induced hemolytic anemia
    ¾à¹°¼º ¿ëÇ÷¼º ºóÇ÷, ¾àÁ¦ À¯¹ß¼º ¿ëÇ÷¼º ºóÇ÷
  • drug-induced immune complex
    ¾àÁ¦ À¯¹ß¼º ¸é¿ª º¹ÇÕü
  • drug-induced leukopenia
    ¾à¹°¼º ¹éÇ÷±¸ °¨¼ÒÁõ
  • drug-induced lupus
    ¾à¹° À¯¹ß ·çǪ½º
  • drug-induced psychosis
    ¾à¹° À¯¹ß Á¤½ÅÁõ
  • drug-induced rhinitis
    ¾à¹° ºñ¿°, ¾à¹°¼º ºñ¿°
    µ¿ÀǾî=rhinitis medicamentosa.
  • drug-induced thrombocytopenic purpura
    ¾à¹°¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹ÝÁõ
  • durg-induced enantheman
    ¾à¹° À¯µµ¼º Á¡¸·Áø
  • induced
    À¯µµµÈ, À¯¹ßµÈ, °¨ÀÀÇÑ, ÃÊ·¡µÈ
    ÀÎÀ§ÀûÀ¸·Î À¯µµµÈ.
  • induced allergy
    À¯¹ß ¾Ë·¹¸£±â, À¯¹ß¼º ¾Ë·¹¸£±â
  • induced enzyme
    À¯µµ È¿¼Ò
    ±âÁú ¶Ç´Â ±×¿Í ±¸Á¶ÀûÀ¸·Î ¿¬°üµÈ, À¯µµ ¹°ÁúÀÇ Àڱؿ¡ ÀÇÇÏ¿© »ý¼ºµÈ È¿¼Ò.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
antibody induced lysis <haematology> The term is imprecise and should not be used since there is confusion as to which mechanism is involved, i.e. Natural killing or complement lysis.
See: complement lysis, natural killer cells.
(09 Feb 1998)
asthma, exercise-induced Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. Inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it).
(12 Dec 1998)
bacteriophage T7 induced DNA polymerase <enzyme> Complex of two proteins, phage gene 5 protein and E coli thioredoxin
Registry number: EC 2.7.7.-
Synonym: t7 phage DNA polymerase, sequenase, t7 DNA polymerase, thermo sequenase
(26 Jun 1999)
carbohydrate-induced hyperlipaemia type III familial hyperlipoproteinaemia, type IV familial hyperlipoproteinaemia
combined fat-and carbohydrate-induced hyperlipaemia Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance.
Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia.
(05 Mar 2000)
contact induced spreading The response in which contact between two epithelial cells leads to a stabilised contact and the increased spreading of the cells so that the area covered is greater than that covered by the two cells in isolation.
(18 Nov 1997)
corticosteroid-induced acne The exacerbation of acne after corticosteroid use is a common drug reaction seen in adolescents. Lessening the dose of the corticosteroid will often diminish this effect.
(27 Sep 1997)
corticosteroid-induced glaucoma <ophthalmology> Glaucoma caused by a hereditary predisposition in which local instillation of eyedrops containing corticosteroid causes increased intraocular pressure.
(05 Mar 2000)
corticosteroid-induced striae <dermatology> High-dose glucocorticoid therapy causes atrophy of the skin and a failure of the normal regenerative process. Purple striae often develop over the individual's trunk or thighs. The colour fades when the drug is stopped, but the dermal atrophy remains.
(27 Sep 1997)
hearing loss, noise-induced Hearing loss from exposure to noise. The loss is often in the frequency range 4000-6000 hertz.
(12 Dec 1998)
heart arrest, induced Arrest of the contraction of the myocardium by the use of cardioplegic chemical compounds (cardioplegic solutions) or of cold during heart surgery.
(12 Dec 1998)
SA-induced protein kinase <enzyme> 48-kD map kinase isolated from nicotiana tabacum; genbank u94192
Registry number: EC 2.7.10.-
Synonym: p48 sip kinase, salicylic acid-induced protein kinase, sipk enzyme
(26 Jun 1999)
hepatitis, chronic, drug-induced An inflammatory disease of the liver, lasting six months or more, and caused by an adverse drug effect. The adverse effect may result from a direct toxic effect of a drug or metabolite, or an idiosyncratic response to a drug or metabolite. The clinical and histological changes can mimic viral or autoimmune hepatitis.
(12 Dec 1998)
psychoses, substance-induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
(12 Dec 1998)
hyperthermia, induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • photoelectric effect
    ±¤ÀüÈ¿°ú
  • ram effect
    ·¥ È¿°ú(±â¼Ó)ÀÇ Áõ°¡¿¡ µû¶ó ÈíÀÔ±¸¿¡ À¯ÀԵǴ °ø±âÀÇ ¾Ð·ÂÀÌ Áõ°¡ÇÏ´Â È¿°ú) '
  • ratchet effect
    ´Ü¼ÓÀû È¿°ú 
  • ripple effect
    ÆÄ±Þ È¿°ú !
  • shot effect,the
    (Áø°ø°üÀÇ À½±Ø¿¡¼­ ¹æ»çµÇ´Â ¿­ÀüÀÚÀÇ)»êź È¿°ú ''
  • side effect
    ºÎÀÛ¿ë
  • skin effect
    (Á֯ļö ÀüµµÃ¼ÀÇ)Ç¥ÇÇ È¿°ú
  • stage effect
    ¹«´ë È¿°ú
  • tunnel effect
    ÅͳΠȿ°ú !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á